ANGELA WILLIAMS: Open Payments
NPI 1427608603 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 69 payments from 14 companies in 2025. Trend: 2023 $69 · 2024 $719 · 2025 $1,373
Food & beverage: $1,254Education: $119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $319 |
| Alkermes, Inc. | 16 | $267 |
| Supernus Pharmaceuticals, Inc. | 12 | $159 |
| Teva Pharmaceuticals USA, Inc. | 3 | $154 |
| Neurocrine BioSciences, Inc. | 4 | $86 |
| Collegium Pharmaceutical, Inc. | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Tempus AI, Inc | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: VRAYLAR, Qelbree, LYBALVI, ARISTADA, INGREZZA, Jornay PM, TRINTELLIX, TEMPUS PIXEL.
Industry payments across TX — which companies pay providers there.
